EX-23.9 9 ea133601ex23-9_aytubio.htm CONSENT OF RSM US LLP RELATING TO NEOS' FINANCIAL STATEMENTS

Exhibit 23.9

Consent of Independent Registered Public Accounting Firm

We consent to the use in this Registration Statement (No. 333-___) on Form S-4 of Aytu BioScience, Inc. of our report dated March 13, 2020, relating to the consolidated financial statements of Neos Therapeutics, Inc. and Subsidiaries, appearing in the joint proxy statement/prospectus, which is part of this Registration Statement. We also consent to the reference to our firm under the heading “Experts” in such Registration Statement.

/s/ RSM US LLP

Dallas, Texas

January 26, 2021